In addition, plasma levels of CXCL13, IL-6 and IL-10 were potential markers for treatment outcomes and survival of patients with AIDS-associated non-Hodgkin lymphoma (NHL) (42). This evidence concerns the gene CXCL13 and non-Hodgkin lymphoma.